* Amarin Corporation PLC AMRN.OQ reported a quarterly
adjusted
loss of 1 cent per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
breakeven earnings per share. The mean expectation of
five analysts for the quarter was for a loss of 3 cents per
share.
* Revenue fell 17.2% to $74.71 million from a year ago;
analysts
expected $63.81 million.
* Amarin Corporation PLC's reported EPS for the quarter was
a loss
of 1 cent.
* The company reported a quarterly loss of $5.78 million.
* Amarin Corporation PLC shares had risen by 51.7% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"
Wall Street's median 12-month price target for Amarin
Corporation PLC is $1.63
This summary was machine generated from LSEG data February 29 at
02:33 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.03 -0.01 Beat
Sep. 30 2023 -0.04 -0.05 Missed
Jun. 30 2023 -0.03 -0.04 Missed
Mar. 31 2023 -0.03 -0.04 Missed